We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $1.85M
1-Year Est. Return 176.16%
This Fund
S&P 500
This Quarter Est. Return
+6.46%
1 Year Est. Return
+176.16%
3 Year Est. Return
+511.75%
5 Year Est. Return
+854.95%
10 Year Est. Return
+8,566.11%
AUM
$92.1M
AUM Growth
+$9.88M
Cap. Flow
+$7.45M
Cap. Flow %
8.09%
Top 10 Hldgs %
95.14%
Holding
26
New
6
Increased
10
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
SCYX icon
SCYNEXIS
SCYX
+$8.4M
2
ICMB icon
Investcorp Credit Management BDC
ICMB
+$6.09M
3
UHAL icon
U-Haul Holding Co
UHAL
+$960K
4
PCG icon
PG&E
PCG
+$955K
5
GARS
Garrison Capital Inc.
GARS
+$936K

Top Sells

Rank Stock Value
1
KALA icon
KALA BIO
KALA
+$10.1M
2
SBBP
Strongbridge Biopharma plc.
SBBP
+$1.04M
3
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
+$214K
4
ADNT icon
Adient
ADNT
+$60K
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$51.7K

Sector Composition

Rank Sector Weight
1 Healthcare 74.96%
2 Financials 20.67%
3 Real Estate 1.51%
4 Utilities 1.07%
5 Industrials 1.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
26
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$814B
– –
-2,519
Closed -$672K
1
2

Similar funds

1IC
1922 Investment Company Houston, Texas $1.89M AUM 15.39% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return
HGCK
HPC Germany & Co KG Potsdam, Germany $1.68M AUM 15.3% 1-Year Est. Return
CA
Cohalo Advisory Snoqualmie, Washington $1.65M AUM 11.44% 1-Year Est. Return
CAM
Creekmur Asset Management Morton, Illinois $2.07M AUM
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.3% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $1.56M AUM 25.68% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Caxton Corporation's Q1 2018 Portfolio in Review

As of Q1 2018, Caxton Corporation held 26 positions worth $92.1M, up 12% from $82.3M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Caxton Corporation deployed $7.45M of net new capital in Q1 2018, opening 6 new positions and adding to 10 existing holdings. Its largest new stake was SCYNEXIS: 60,880 shares worth $6.53M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 82% a quarter earlier, followed by Financials and Real Estate.

On the sell side, the largest reduction was Strongbridge Biopharma plc., an estimated $1.04M trimmed.

  • Caxton Corporation's largest Q1 2018 buy was SCYNEXIS: 60,880 shares worth $6.53M.
  • Caxton Corporation added most to Investcorp Credit Management BDC in Q1 2018, an estimated $6.09M increase.
  • Caxton Corporation's biggest Q1 2018 reduction was Strongbridge Biopharma plc., cutting an estimated $1.04M.
  • Caxton Corporation fully exited KALA BIO in Q1 2018, selling an estimated $10.1M.
  • Caxton Corporation's ten largest holdings make up 95% of its $92.1M portfolio in Q1 2018.
  • Caxton Corporation opened 6 new positions and closed 3 in Q1 2018.
  • Caxton Corporation's portfolio value rose 12% quarter-over-quarter to $92.1M.

Based on Caxton Corporation's 13F filing for Q1 2018, filed 15 May 2018.